Status:
COMPLETED
Delayed Postconditioning
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Myocardial Reperfusion Injury
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The investigators previously reported that angioplasty postconditioning reduces infarct size (cardiac enzyme release) in STEMI patients with a fully occluded coronary artery at hospital admission. Ani...
Eligibility Criteria
Inclusion
- Patient \> 18 years old
- Male or female
- Presenting first myocardial infarction, with the beginning of pains \< 12 hours,
- Requiring a revascularisation by primary angioplasty or " rescue " (after failure of thrombolysis) on LAD or RCA (not Circumflex coronary artery).
- TIMI flow grade at admission of 2 or 3
- LV angiography (RAO30°) before angioplasty.
Exclusion
- Cardiac arrest before the angioplasty
- Cardiogenic shock
- Occlusion of the artery circumflex responsible for the infarction
- Visible collaterals to the area at risk
- Magnetic resonance imaging: contra indication
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT01483755
Start Date
July 1 2009
End Date
June 1 2012
Last Update
December 19 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Cardiologie, CHU d'Angers
Angers, France, 49933
2
Service d'explorations Fonctionnelles Cardiovasculaires, Hôpital Cardiologique Louis Pradel
Bron, France, 69677
3
Service de Cardiologie, Hôpital Arnaud de Villeneuve
Montpellier, France, 34295
4
Service de Cardiologie, Hôpital Emile Müller
Mulhouse, France, 68051